Vistusertib
Vistusertib is an oral serine/threonine kinase inhibitor from AstraZeneca, in registered phase 2 trials for non-small-cell lung cancer, small-cell lung cancer.
Overview
Vistusertib is listed on ClinicalTrials.gov as an intervention in 1 registered phase 2 trial sponsored by AstraZeneca, in non-small-cell lung cancer, small-cell lung cancer. A serine/threonine kinase inhibitor: the name stem -sertib marks a small molecule that blocks a kinase in this family. OnCo records the agent from the registry alone; approvals, results and the sponsor's own description will follow as they are published.
A serine/threonine kinase inhibitor: the name stem -sertib marks a small molecule that blocks a kinase in this family.
1.Vistusertib slips into a pocket on its target.
Trials
topTrials recruiting now
Country and place are remembered in this browser only. A postcode is sent to OpenStreetMap's Nominatim service to find coordinates when you press the button; nothing else leaves your device.
Landmark trials
Latest papers
topQuery for this drug: (TITLE:"Vistusertib" OR ABSTRACT:"Vistusertib") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about Vistusertib, not a curated reading list.
Similar pages
not linked directly; found by shared links- TreatmentAU-007
Shares Small-cell lung cancer, Non-small-cell lung cancer and the tags pipeline, registry-only.
- TreatmentOR502
Shares Small-cell lung cancer, Non-small-cell lung cancer and the tags pipeline, registry-only.
- TreatmentTNG260
Shares Small-cell lung cancer, Non-small-cell lung cancer and the tags pipeline, registry-only.
- TreatmentTNO155
Shares Small-cell lung cancer, Non-small-cell lung cancer and the tags pipeline, registry-only.
- TreatmentAMT-116
Shares Small-cell lung cancer, Non-small-cell lung cancer and the tags pipeline, registry-only.
- TreatmentRoginolisib
Shares Small-cell lung cancer, Non-small-cell lung cancer and the tags pipeline, registry-only.
- TreatmentAZD8421
Shares AstraZeneca and the tags pipeline, registry-only.
- TreatmentAdavosertib
Shares AstraZeneca and the tags pipeline, registry-only.